<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3045689/" ref="ordinalpos=226&amp;ncbi_uid=2811753&amp;link_uid=PMC3045689" image-link="/pmc/articles/PMC3045689/figure/F4/" class="imagepopup">Fig. 4.  From: Rebamipide suppresses TLR-TBK1 <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span> resulting in regulating IRF3/7 and IFN-?/? reduction. </a></div><br /><div class="p4l_captionBody">Rebamipide suppressed TBK1-IRF3/7-IFN-α/β signaling pathway in DSS mice. Effect of rebamipide on TLR-TBK1 signaling pathway in colon specimens from mice given oral DDS examined by real-time RT-PCR of TBK1, IRF3, IRF7, IFN-α and IFN-β. Messenger RNA expression of these genes was increased because of colonic inflammation in DSS mice, but this increase was suppressed in DSS mice given daily rectal rebamipide.</div></div>